Healthcare Sector Stocks
The Healthcare sector has a total of 1053 stocks, with a combined market cap of $9.87 trillion, total revenue of $4.69 trillion and a weighted average PE ratio of 50.71.
Market Cap
9.87T
Revenue
4.69T
Profits
194.69B
PE Ratio
50.71
Profit Margin
4.15%
Dividend Yield
0.37%
1053 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.22T | 6.63% | 4,373,521 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 662.49B | 1.53% | 6,023,569 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 513.86B | 1.68% | 4,329,287 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 368.83B | 0.94% | 3,795,863 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 361.02B | 3.83% | 13,447,648 | 67.38B |
| 6 | NVS | Novartis AG | 302.38B | 3.22% | 2,237,115 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 270.72B | 2.88% | 3,715,613 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 262.22B | 0.71% | 1,473,478 | 47.35B |
| 9 | AMGN | Amgen Inc. | 249.09B | 1.97% | 2,982,878 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 205.35B | 4.03% | 8,431,613 | 30.99B |
| 11 | ABT | Abbott Laboratories | 180.95B | 1.88% | 7,285,423 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 171.97B | 2.22% | 10,441,293 | 50.34B |
| 13 | PFE | Pfizer Inc. | 170.71B | 1.70% | 34,259,422 | 63.70B |
| 14 | DHR | Danaher Corporation | 166.72B | 1.24% | 2,702,439 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 155.56B | 1.03% | 1,891,743 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 136.87B | 1.95% | 1,542,075 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 125.40B | 1.35% | 14,767,598 | 50.03B |
| 18 | SYK | Stryker Corporation | 119.58B | 2.55% | 3,077,093 | 26.30B |
| 19 | MDT | Medtronic plc | 118.88B | 2.46% | 9,375,743 | 37.54B |
| 20 | CVS | CVS Health Corporation | 115.53B | 0.42% | 10,231,904 | 412.65B |
| 21 | MCK | McKesson Corporation | 114.36B | 2.12% | 721,491 | 410.98B |
| 22 | HCA | HCA Healthcare, Inc. | 103.51B | 3.21% | 1,264,408 | 78.70B |
| 23 | SNY | Sanofi | 101.86B | 2.11% | 4,266,368 | 55.89B |
| 24 | GSK | GSK plc | 97.25B | -0.12% | 5,610,326 | 44.53B |
| 25 | ELV | Elevance Health, Inc. | 91.18B | 1.84% | 1,037,583 | 201.83B |
| 26 | MRNA | Moderna, Inc. | 88.93B | 4.01% | 10,834,628 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 81.76B | 0.68% | 789,303 | 15.53B |
| 28 | CI | The Cigna Group | 78.85B | 1.16% | 1,269,482 | 282.38B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 67.28B | -0.69% | 4,805,491 | 28.42B |
| 30 | COR | Cencora, Inc. | 63.07B | 1.91% | 1,025,271 | 332.77B |
| 31 | NTRA | Natera, Inc. | 62.85B | 2.73% | 1,326,459 | 2.71B |
| 32 | BSX | Boston Scientific Corporation | 61.87B | 0.61% | 31,755,378 | 21.07B |
| 33 | CAH | Cardinal Health, Inc. | 58.14B | 2.59% | 1,739,294 | 254.25B |
| 34 | ARGX | argenx SE | 56.16B | 0.68% | 160,887 | 5.92B |
| 35 | EW | Edwards Lifesciences Corporation | 54.44B | 2.90% | 4,680,786 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 54.03B | 1.63% | 2,200,098 | 22.48B |
| 37 | A | Agilent Technologies, Inc. | 51.07B | -0.18% | 1,824,909 | 7.37B |
| 38 | VEEV | Veeva Systems Inc. | 50.25B | -2.35% | 1,792,618 | 3.46B |
| 39 | HUM | Humana Inc. | 50.14B | 1.38% | 1,024,034 | 145.68B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 48.32B | 3.75% | 5,232,433 | 17.32B |
| 41 | WAT | Waters Corporation | 47.17B | 0.67% | 883,054 | 4.64B |
| 42 | IDXX | IDEXX Laboratories, Inc. | 45.38B | 2.32% | 479,539 | 4.55B |
| 43 | IQV | IQVIA Holdings Inc. | 45.33B | -1.43% | 1,430,077 | 17.31B |
| 44 | ILMN | Illumina, Inc. | 43.80B | 0.44% | 2,035,239 | 4.54B |
| 45 | ONC | BeOne Medicines AG | 42.25B | -0.48% | 268,142 | 6.13B |
| 46 | MDLN | Medline Inc. | 42.07B | -1.14% | 15,890,552 | 29.94B |
| 47 | RVMD | Revolution Medicines, Inc. | 40.78B | 0.82% | 1,324,028 | - |
| 48 | RPRX | Royalty Pharma plc | 37.91B | 1.71% | 2,450,453 | 2.54B |
| 49 | HLN | Haleon plc | 37.43B | -14.30% | 56,763,396 | 14.80B |
| 50 | BIIB | Biogen Inc. | 36.90B | 2.29% | 1,157,855 | 10.30B |
| 51 | RMD | ResMed Inc. | 35.56B | 1.06% | 1,450,972 | 5.73B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 34.55B | 0.79% | 4,646,513 | 21.64B |
| 53 | MTD | Mettler-Toledo International Inc. | 34.44B | 1.19% | 129,407 | 4.13B |
| 54 | ALC | Alcon Inc. | 34.37B | 1.86% | 1,255,507 | 10.86B |
| 55 | CNC | Centene Corporation | 33.97B | 2.34% | 5,628,640 | 180.41B |
| 56 | GMAB | Genmab A/S | 33.80B | -1.40% | 6,253,145 | 4.13B |
| 57 | ZTS | Zoetis Inc. | 32.56B | 1.29% | 2,936,472 | 9.53B |
| 58 | DXCM | DexCom, Inc. | 30.16B | 1.67% | 5,923,570 | 5.10B |
| 59 | LH | Labcorp Holdings Inc. | 29.89B | 2.20% | 1,144,317 | 14.59B |
| 60 | WST | West Pharmaceutical Services, Inc. | 29.03B | 3.23% | 1,873,146 | 3.40B |
| 61 | DGX | Quest Diagnostics Incorporated | 27.83B | 2.97% | 946,276 | 11.84B |
| 62 | ROIV | Roivant Sciences Ltd. | 27.10B | 1.10% | 3,728,827 | 7.53M |
| 63 | PHG | Koninklijke Philips N.V. | 26.50B | 0.33% | 812,190 | 20.18B |
| 64 | UTHR | United Therapeutics Corporation | 25.46B | 1.20% | 370,341 | 3.15B |
| 65 | GH | Guardant Health, Inc. | 24.87B | 1.49% | 1,245,559 | 1.18B |
| 66 | INSM | Insmed Incorporated | 24.37B | 15.06% | 11,220,668 | 1.52B |
| 67 | INCY | Incyte Corporation | 23.68B | -0.06% | 3,047,641 | 6.01B |
| 68 | ALNY | Alnylam Pharmaceuticals, Inc. | 23.28B | -25.13% | 11,802,855 | 5.01B |
| 69 | STE | STERIS plc | 22.63B | 1.47% | 485,782 | 6.04B |
| 70 | BNTX | BioNTech SE | 22.39B | 1.30% | 692,716 | 3.03B |
| 71 | VTRS | Viatris Inc. | 22.05B | 2.29% | 10,494,572 | 14.74B |
| 72 | THC | Tenet Healthcare Corporation | 21.79B | 0.77% | 1,460,581 | 22.15B |
| 73 | MEDP | Medpace Holdings, Inc. | 18.95B | -2.18% | 250,425 | 2.84B |
| 74 | ZBH | Zimmer Biomet Holdings, Inc. | 18.59B | 1.12% | 2,041,135 | 8.51B |
| 75 | RVTY | Revvity, Inc. | 18.50B | 0.27% | 1,529,877 | 2.91B |
| 76 | CRL | Charles River Laboratories International, Inc. | 17.95B | 0.57% | 887,342 | 4.00B |
| 77 | ASND | Ascendis Pharma A/S | 16.62B | 1.38% | 491,410 | 1.20B |
| 78 | EXEL | Exelixis, Inc. | 16.40B | -0.12% | 2,839,243 | 2.50B |
| 79 | ICLR | ICON Public Limited Company | 16.14B | 0.62% | 1,797,085 | 8.23B |
| 80 | HALO | Halozyme Therapeutics, Inc. | 14.89B | 0.88% | 1,875,468 | 1.66B |
| 81 | NBIX | Neurocrine Biosciences, Inc. | 14.88B | 0.58% | 831,120 | 3.37B |
| 82 | GKOS | Glaukos Corporation | 14.35B | 33.65% | 5,416,242 | 690.33M |
| 83 | SOLV | Solventum Corporation | 14.22B | 2.09% | 1,088,684 | 8.31B |
| 84 | TEM | Tempus AI, Inc. | 14.05B | 1.61% | 4,854,753 | 1.43B |
| 85 | BBIO | BridgeBio Pharma, Inc. | 13.83B | -0.13% | 4,933,751 | 945.54M |
| 86 | JAZZ | Jazz Pharmaceuticals plc | 13.49B | 1.35% | 773,589 | 4.60B |
| 87 | EHC | Encompass Health Corporation | 12.97B | 7.70% | 2,197,540 | 6.34B |
| 88 | SMMT | Summit Therapeutics Inc. | 12.96B | 2.73% | 4,415,071 | - |
| 89 | PEN | Penumbra, Inc. | 12.68B | 1.15% | 672,771 | 1.56B |
| 90 | SNN | Smith & Nephew plc | 12.55B | 0.96% | 1,566,378 | 6.30B |
| 91 | BTSG | BrightSpring Health Services, Inc. | 12.55B | 1.28% | 3,983,893 | 14.37B |
| 92 | FMS | Fresenius Medical Care AG | 12.27B | 2.25% | 1,361,108 | 22.19B |
| 93 | DVA | DaVita Inc. | 12.16B | 5.10% | 2,077,970 | 14.17B |
| 94 | BAX | Baxter International Inc. | 12.15B | -7.70% | 15,670,050 | 11.61B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 11.81B | -0.28% | 2,112,546 | 3.44B |
| 96 | ELAN | Elanco Animal Health Incorporated | 11.61B | 2.60% | 3,488,765 | 5.02B |
| 97 | COO | The Cooper Companies, Inc. | 11.47B | 1.57% | 1,759,142 | 4.24B |
| 98 | TECH | Bio-Techne Corporation | 11.40B | 0.03% | 2,888,172 | 1.22B |
| 99 | AVTR | Avantor, Inc. | 11.30B | -0.06% | 11,218,125 | 6.64B |
| 100 | GMED | Globus Medical, Inc. | 11.13B | 2.03% | 861,914 | 3.14B |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 11.13B | 2.66% | 2,617,634 | 3.41B |
| 102 | ALGN | Align Technology, Inc. | 10.92B | 0.06% | 2,007,595 | 4.16B |
| 103 | TWST | Twist Bioscience Corporation | 10.88B | - | 1,777,965 | 431.80M |
| 104 | ENSG | The Ensign Group, Inc. | 10.78B | 1.20% | 465,449 | 5.67B |
| 105 | RGEN | Repligen Corporation | 10.69B | 2.14% | 890,267 | 805.61M |
| 106 | TXG | 10x Genomics, Inc. | 10.63B | -2.48% | 1,860,048 | 616.91M |
| 107 | PODD | Insulet Corporation | 10.58B | 2.40% | 1,297,218 | 3.05B |
| 108 | QGEN | Qiagen N.V. | 10.41B | 0.02% | 3,549,441 | 2.10B |
| 109 | UHS | Universal Health Services, Inc. | 10.41B | 2.57% | 1,005,133 | 18.35B |
| 110 | MOH | Molina Healthcare, Inc. | 10.36B | 0.43% | 635,677 | 42.08B |
| 111 | BIO | Bio-Rad Laboratories, Inc. | 10.28B | -0.19% | 332,347 | 2.59B |
| 112 | CAI | Caris Life Sciences, Inc. | 10.21B | 1.95% | 3,787,234 | 989.61M |
| 113 | KYMR | Kymera Therapeutics, Inc. | 10.19B | 0.07% | 1,045,368 | 102.24M |
| 114 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.97B | 0.16% | 268,026 | 1.28B |
| 115 | PCVX | Vaxcyte, Inc. | 9.85B | 1.87% | 2,013,891 | - |
| 116 | HSIC | Henry Schein, Inc. | 9.63B | 1.74% | 924,680 | 13.60B |
| 117 | KRYS | Krystal Biotech, Inc. | 9.61B | 0.97% | 190,769 | 440.48M |
| 118 | OSCR | Oscar Health, Inc. | 9.49B | 1.02% | 3,514,914 | 15.32B |
| 119 | BRKR | Bruker Corporation | 9.45B | - | 1,502,665 | 3.50B |
| 120 | HNGE | Hinge Health, Inc. | 9.43B | 1.41% | 2,142,641 | 720.06M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.34B | 1.55% | 325,558 | 281.99M |
| 122 | CORT | Corcept Therapeutics Incorporated | 9.29B | -0.38% | 1,185,786 | 830.81M |
| 123 | IBRX | ImmunityBio, Inc. | 9.26B | -0.79% | 7,148,335 | 165.79M |
| 124 | SYRE | Spyre Therapeutics, Inc. | 9.25B | -0.79% | 567,637 | - |
| 125 | CYTK | Cytokinetics, Incorporated | 8.80B | 3.31% | 1,425,391 | 67.67M |
| 126 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.54B | 0.47% | 1,275,721 | 669.50M |
| 127 | HQY | HealthEquity, Inc. | 8.38B | 0.02% | 596,637 | 1.36B |
| 128 | ATR | AptarGroup, Inc. | 8.31B | 2.73% | 649,741 | 3.99B |
| 129 | TGTX | TG Therapeutics, Inc. | 8.24B | 1.18% | 1,789,197 | 799.54M |
| 130 | PRAX | Praxis Precision Medicines, Inc. | 8.06B | 1.10% | 508,543 | 7.46M |
| 131 | ABVX | ABIVAX Société Anonyme | 7.89B | -0.87% | 595,985 | 5.33M |
| 132 | PACS | PACS Group, Inc. | 7.87B | 1.26% | 896,405 | 5.55B |
| 133 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.67B | 2.50% | 1,380,254 | 945.96M |
| 134 | ALKS | Alkermes plc | 7.61B | 0.27% | 1,427,248 | 1.67B |
| 135 | AXSM | Axsome Therapeutics, Inc. | 7.51B | -0.04% | 850,520 | 776.57M |
| 136 | AMRX | Amneal Pharmaceuticals, Inc. | 7.44B | 0.99% | 4,400,170 | 3.12B |
| 137 | IONS | Ionis Pharmaceuticals, Inc. | 7.38B | -1.14% | 1,833,849 | 874.09M |
| 138 | BLCO | Bausch + Lomb Corporation | 7.29B | - | 3,451,995 | 5.42B |
| 139 | GRFS | Grifols, S.A. | 7.12B | -0.99% | 273,389 | 8.48B |
| 140 | GRAL | GRAIL, Inc. | 7.10B | 0.66% | 761,501 | 165.26M |
| 141 | CHE | Chemed Corporation | 7.05B | 1.60% | 193,522 | 2.66B |
| 142 | HIMS | Hims & Hers Health, Inc. | 6.92B | 1.19% | 7,519,682 | 2.58B |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.55B | 0.22% | 771,656 | 1.56B |
| 144 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.41B | 1.20% | 760,469 | 239.92M |
| 145 | ORKA | Oruka Therapeutics, Inc. | 6.40B | 0.71% | 657,291 | - |
| 146 | LGND | Ligand Pharmaceuticals Incorporated | 6.33B | -0.45% | 299,391 | 306.90M |
| 147 | KOD | Kodiak Sciences Inc. | 6.30B | 3.46% | 1,174,178 | - |
| 148 | IMVT | Immunovant, Inc. | 6.12B | 0.75% | 1,399,315 | - |
| 149 | BLTE | Belite Bio, Inc | 6.05B | 1.05% | 93,256 | - |
| 150 | MANE | Veradermics, Incorporated | 6.01B | 0.01% | 513,585 | - |
| 151 | DOCS | Doximity, Inc. | 5.99B | -1.81% | 2,727,982 | 655.57M |
| 152 | TFX | Teleflex Incorporated | 5.99B | 1.73% | 837,979 | 2.25B |
| 153 | RDNT | RadNet, Inc. | 5.80B | 0.15% | 472,096 | 2.27B |
| 154 | CGON | CG Oncology, Inc. | 5.63B | -0.77% | 782,618 | 6.23M |
| 155 | MIRM | Mirum Pharmaceuticals, Inc. | 5.61B | 0.68% | 591,323 | 618.07M |
| 156 | MMSI | Merit Medical Systems, Inc. | 5.58B | 1.28% | 979,228 | 1.61B |
| 157 | COGT | Cogent Biosciences, Inc. | 5.55B | -0.84% | 1,515,524 | - |
| 158 | STVN | Stevanato Group S.p.A. | 5.53B | 4.17% | 405,417 | 1.40B |
| 159 | HAE | Haemonetics Corporation | 5.45B | 1.24% | 558,543 | 1.35B |
| 160 | BLLN | BillionToOne, Inc. | 5.42B | 0.74% | 583,182 | 397.41M |
| 161 | MMED | MiniMed Group, Inc. | 5.42B | 0.21% | 7,334,549 | 3.22B |
| 162 | WAY | Waystar Holding Corp. | 5.41B | -2.46% | 1,725,616 | 1.21B |
| 163 | SRRK | Scholar Rock Holding Corporation | 5.38B | 2.15% | 1,288,639 | - |
| 164 | PTCT | PTC Therapeutics, Inc. | 5.38B | 2.28% | 1,524,173 | 1.16B |
| 165 | SHC | Sotera Health Company | 5.34B | 0.27% | 2,528,710 | 1.22B |
| 166 | HTFL | HeartFlow, Inc. | 5.26B | 2.42% | 1,299,737 | 212.07M |
| 167 | CON | Concentra Group Holdings Parent, Inc. | 5.26B | 1.63% | 1,413,259 | 2.29B |
| 168 | CRSP | CRISPR Therapeutics AG | 5.25B | 0.28% | 1,314,284 | 13.39M |
| 169 | ERAS | Erasca, Inc. | 5.24B | -0.93% | 2,280,743 | - |
| 170 | LFST | LifeStance Health Group, Inc. | 5.21B | 1.83% | 2,470,381 | 1.58B |
| 171 | DFTX | Definium Therapeutics, Inc. | 5.10B | -0.37% | 1,419,618 | - |
| 172 | OPCH | Option Care Health, Inc. | 4.77B | 1.79% | 11,823,884 | 5.69B |
| 173 | TVTX | Travere Therapeutics, Inc. | 4.77B | -0.55% | 1,573,533 | 591.33M |
| 174 | DNTH | Dianthus Therapeutics, Inc. | 4.63B | 0.47% | 849,063 | 1.90M |
| 175 | ADPT | Adaptive Biotechnologies Corporation | 4.50B | -0.70% | 2,588,870 | 308.08M |
| 176 | LIVN | LivaNova PLC | 4.48B | 0.73% | 483,322 | 1.47B |
| 177 | IOVA | Iovance Biotherapeutics, Inc. | 4.33B | -35.45% | 59,227,867 | 324.97M |
| 178 | LEGN | Legend Biotech Corporation | 4.32B | -1.02% | 2,374,599 | 1.27B |
| 179 | ITGR | Integer Holdings Corporation | 4.30B | -0.02% | 684,260 | 1.83B |
| 180 | RLAY | Relay Therapeutics, Inc. | 4.27B | -1.12% | 1,945,349 | 10.35M |
| 181 | ABCL | AbCellera Biologics Inc. | 4.24B | -4.11% | 2,618,444 | 66.17M |
| 182 | EWTX | Edgewise Therapeutics, Inc. | 4.23B | -3.90% | 1,209,623 | - |
| 183 | ICUI | ICU Medical, Inc. | 4.22B | 1.36% | 202,496 | 2.16B |
| 184 | IRTC | iRhythm Holdings, Inc. | 4.21B | 3.07% | 550,252 | 825.34M |
| 185 | VCYT | Veracyte, Inc. | 4.19B | 3.70% | 1,231,658 | 561.90M |
| 186 | INDV | Indivior Pharmaceuticals, Inc. | 4.16B | 1.38% | 5,720,373 | 1.37B |
| 187 | LQDA | Liquidia Corporation | 4.03B | -1.60% | 2,638,797 | 450.91M |
| 188 | ARQT | Arcutis Biotherapeutics, Inc. | 4.02B | 1.65% | 1,752,959 | 463.98M |
| 189 | PLSE | Pulse Biosciences, Inc. | 3.96B | 3.37% | 344,679 | 1.19M |
| 190 | NVST | Envista Holdings Corporation | 3.95B | 2.80% | 2,924,719 | 2.86B |
| 191 | TNGX | Tango Therapeutics, Inc. | 3.80B | 1.35% | 3,370,049 | 53.81M |
| 192 | CDNA | CareDx, Inc. | 3.70B | -0.85% | 1,692,145 | 497.40M |
| 193 | IRON | Disc Medicine, Inc. | 3.68B | -0.43% | 688,358 | - |
| 194 | XENE | Xenon Pharmaceuticals Inc. | 3.64B | 3.30% | 1,553,584 | 7.50M |
| 195 | OGN | Organon & Co. | 3.63B | 0.22% | 2,510,119 | 6.13B |
| 196 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.60B | 2.17% | 905,466 | -665.00K |
| 197 | ACAD | Acadia Pharmaceuticals Inc. | 3.58B | 2.17% | 2,193,810 | 1.14B |
| 198 | PBLS | Parabilis Medicines, Inc. | 3.55B | 1.88% | 844,732 | 148.00K |
| 199 | VKTX | Viking Therapeutics, Inc. | 3.43B | 5.91% | 6,753,816 | - |
| 200 | RGC | Regencell Bioscience Holdings Limited | 3.40B | -5.64% | 183,628 | - |
| 201 | CELC | Celcuity Inc. | 3.39B | -0.23% | 820,623 | - |
| 202 | BHC | Bausch Health Companies Inc. | 3.33B | 28.76% | 33,781,852 | 11.11B |
| 203 | NHC | National HealthCare Corporation | 3.32B | 0.17% | 145,601 | 1.56B |
| 204 | ELVN | Enliven Therapeutics, Inc. | 3.30B | 0.67% | 909,464 | - |
| 205 | TARS | Tarsus Pharmaceuticals, Inc. | 3.26B | 2.98% | 458,416 | 606.33M |
| 206 | DYN | Dyne Therapeutics, Inc. | 3.18B | 0.35% | 1,427,329 | - |
| 207 | ATRC | AtriCure, Inc. | 3.18B | 1.73% | 702,374 | 569.62M |
| 208 | IDYA | IDEAYA Biosciences, Inc. | 3.17B | -3.15% | 1,623,974 | 234.13M |
| 209 | TLX | Telix Pharmaceuticals Limited | 3.14B | 2.70% | 211,313 | 890.79M |
| 210 | DNLI | Denali Therapeutics Inc. | 3.09B | 0.16% | 1,449,892 | 3.60M |
| 211 | WRBY | Warby Parker Inc. | 3.04B | 0.65% | 2,598,766 | 911.61M |
| 212 | SGRY | Surgery Partners, Inc. | 3.01B | -0.13% | 3,535,069 | 3.37B |
| 213 | AXGN | Axogen, Inc. | 2.96B | 0.77% | 2,280,989 | 266.93M |
| 214 | NRIX | Nurix Therapeutics, Inc. | 2.96B | -0.51% | 2,375,189 | 701.94M |
| 215 | AVAH | Aveanna Healthcare Holdings Inc. | 2.89B | 1.53% | 2,327,090 | 2.60B |
| 216 | BEAM | Beam Therapeutics Inc. | 2.88B | 0.21% | 2,000,785 | 156.04M |
| 217 | VRDN | Viridian Therapeutics, Inc. | 2.81B | 2.18% | 1,907,021 | 71.13M |
| 218 | PRVA | Privia Health Group, Inc. | 2.81B | 0.71% | 868,988 | 2.36B |
| 219 | ZLAB | Zai Lab Limited | 2.78B | -2.95% | 648,512 | 449.61M |
| 220 | ACHC | Acadia Healthcare Company, Inc. | 2.74B | -0.17% | 2,738,263 | 3.37B |
| 221 | NEOG | Neogen Corporation | 2.68B | 1.16% | 3,225,842 | 884.00M |
| 222 | RCUS | Arcus Biosciences, Inc. | 2.68B | 1.20% | 1,665,762 | 117.00M |
| 223 | ADMA | ADMA Biologics, Inc. | 2.63B | 4.17% | 2,744,752 | 512.28M |
| 224 | MBX | MBX Biosciences, Inc. | 2.63B | 0.70% | 257,205 | - |
| 225 | GRDN | Guardian Pharmacy Services, Inc. | 2.56B | 0.30% | 207,978 | 1.46B |
| 226 | RXRX | Recursion Pharmaceuticals, Inc. | 2.53B | -2.53% | 20,964,655 | 54.86M |
| 227 | BHVN | Biohaven Ltd. | 2.49B | 6.25% | 2,450,829 | - |
| 228 | NAMS | NewAmsterdam Pharma Company N.V. | 2.48B | -1.47% | 1,029,059 | 7.12M |
| 229 | BKD | Brookdale Senior Living Inc. | 2.45B | 2.91% | 4,206,985 | 2.93B |
| 230 | CLOV | Clover Health Investments, Corp. | 2.43B | -4.38% | 4,070,812 | 2.48B |
| 231 | SUPN | Supernus Pharmaceuticals, Inc. | 2.43B | 1.85% | 1,885,193 | 865.11M |
| 232 | PGEN | Precigen, Inc. | 2.38B | 9.21% | 7,742,784 | 85.72M |
| 233 | ALMR | Alamar Biosciences, Inc. | 2.36B | -0.76% | 496,145 | 100.42M |
| 234 | PHVS | Pharvaris N.V. | 2.36B | 2.32% | 877,868 | - |
| 235 | HCM | HUTCHMED (China) Limited | 2.35B | 2.03% | 34,276 | 549.12M |
| 236 | CLDX | Celldex Therapeutics, Inc. | 2.35B | 0.78% | 918,867 | 158.00K |
| 237 | TMDX | TransMedics Group, Inc. | 2.33B | 0.33% | 991,427 | 668.47M |
| 238 | NEO | NeoGenomics, Inc. | 2.32B | -0.33% | 3,758,971 | 787.75M |
| 239 | MD | Pediatrix Medical Group, Inc. | 2.31B | 0.93% | 832,558 | 1.96B |
| 240 | PBH | Prestige Consumer Healthcare Inc. | 2.31B | 2.01% | 343,411 | 1.10B |
| 241 | AUPH | Aurinia Pharmaceuticals Inc. | 2.29B | -0.86% | 744,724 | 311.51M |
| 242 | ADUS | Addus HomeCare Corporation | 2.27B | 1.77% | 331,545 | 1.48B |
| 243 | UFPT | UFP Technologies, Inc. | 2.27B | 2.55% | 107,532 | 631.64M |
| 244 | HRMY | Harmony Biosciences Holdings, Inc. | 2.25B | 0.23% | 778,849 | 959.90M |
| 245 | SDGR | Schrödinger, Inc. | 2.24B | -2.85% | 1,364,798 | 259.04M |
| 246 | FTRE | Fortrea Holdings Inc. | 2.23B | -10.61% | 4,953,134 | 2.67B |
| 247 | AGIO | Agios Pharmaceuticals, Inc. | 2.22B | -2.33% | 984,412 | 98.34M |
| 248 | PRGO | Perrigo Company plc | 2.21B | -0.13% | 2,288,812 | 4.14B |
| 249 | VERA | Vera Therapeutics, Inc. | 2.20B | -1.33% | 1,108,647 | - |
| 250 | VCEL | Vericel Corporation | 2.20B | 4.43% | 544,832 | 306.30M |
| 251 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.20B | -0.47% | 1,385,342 | 208.78M |
| 252 | PVLA | Palvella Therapeutics, Inc. | 2.18B | 2.79% | 342,962 | - |
| 253 | PGNY | Progyny, Inc. | 2.18B | 1.90% | 657,470 | 1.31B |
| 254 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.18B | 1.79% | 4,519,170 | 940.61M |
| 255 | XNCR | Xencor, Inc. | 2.17B | -2.60% | 931,196 | 104.97M |
| 256 | WGS | GeneDx Holdings Corp. | 2.12B | 9.79% | 921,746 | 454.43M |
| 257 | SEPN | Septerna, Inc. | 2.11B | 2.21% | 200,692 | 98.88M |
| 258 | IMNM | Immunome, Inc. | 2.08B | -2.51% | 877,926 | 4.02M |
| 259 | ABSI | Absci Corporation | 2.08B | 1.85% | 4,337,281 | 1.56M |
| 260 | LKFT | Lakefront Biotherapeutics NV | 2.07B | 0.78% | 245,964 | 1.13B |
| 261 | MESO | Mesoblast Limited | 2.07B | 17.03% | 698,517 | 120.25M |
| 262 | INSP | Inspire Medical Systems, Inc. | 2.06B | 0.30% | 512,569 | 898.74M |
| 263 | SLS | SELLAS Life Sciences Group, Inc. | 2.05B | -2.17% | 8,357,645 | - |
| 264 | TRLV | Trulieve Cannabis Corp. | 2.04B | -0.19% | 1,034,341 | 1.14B |
| 265 | ESTA | Establishment Labs Holdings Inc. | 2.04B | -0.81% | 1,043,208 | 264.03M |
| 266 | ZYME | Zymeworks Inc. | 2.04B | -0.66% | 806,234 | 37.13M |
| 267 | SRPT | Sarepta Therapeutics, Inc. | 2.03B | -0.47% | 1,188,092 | 1.97B |
| 268 | GENB | Generate Biomedicines, Inc. | 2.02B | 2.54% | 1,762,119 | 26.48M |
| 269 | BFLY | Butterfly Network, Inc. | 2.01B | -3.84% | 5,904,678 | 123.26M |
| 270 | ADRX | ADARx Pharmaceuticals, Inc. | 2.00B | -0.56% | 402,002 | 6.13M |
| 271 | VIR | Vir Biotechnology, Inc. | 1.99B | -1.51% | 1,421,802 | 303.23M |
| 272 | TRVI | Trevi Therapeutics, Inc. | 1.97B | 2.14% | 1,345,315 | - |
| 273 | XERS | Xeris Biopharma Holdings, Inc. | 1.96B | 1.03% | 1,745,555 | 335.41M |
| 274 | LMAT | LeMaitre Vascular, Inc. | 1.95B | 2.90% | 300,113 | 262.43M |
| 275 | XRAY | DENTSPLY SIRONA Inc. | 1.92B | 1.80% | 3,552,491 | 3.64B |
| 276 | TRAX | First Tracks Biotherapeutics, Inc. | 1.90B | -1.08% | 471,669 | - |
| 277 | COAG | Hemab Therapeutics Holdings, Inc. | 1.89B | 4.99% | 1,195,912 | - |
| 278 | MLYS | Mineralys Therapeutics, Inc. | 1.88B | -0.65% | 2,077,152 | - |
| 279 | ZBIO | Zenas BioPharma, Inc. | 1.87B | -0.03% | 373,026 | 1.00M |
| 280 | ASTH | Astrana Health, Inc. | 1.87B | -0.14% | 256,141 | 3.84B |
| 281 | NTLA | Intellia Therapeutics, Inc. | 1.85B | -0.68% | 4,703,736 | 59.51M |
| 282 | KMTS | Kestra Medical Technologies, Ltd. | 1.82B | 2.48% | 470,656 | 106.73M |
| 283 | AMN | AMN Healthcare Services, Inc. | 1.82B | 0.47% | 498,596 | 3.43B |
| 284 | AZTA | Azenta, Inc. | 1.81B | 1.58% | 829,510 | 613.81M |
| 285 | ATEC | Alphatec Holdings, Inc. | 1.76B | -0.70% | 7,217,778 | 839.72M |
| 286 | QURE | uniQure N.V. | 1.75B | 1.32% | 1,713,389 | 18.67M |
| 287 | ALVO | Alvotech | 1.75B | -1.01% | 373,364 | 494.61M |
| 288 | KLRA | Kailera Therapeutics, Inc. | 1.74B | -0.07% | 1,044,492 | - |
| 289 | ARDT | Ardent Health, Inc. | 1.73B | 3.10% | 602,600 | 6.41B |
| 290 | BRVE | Braveheart Bio, Inc. | 1.73B | -2.62% | 304,126 | - |
| 291 | NVAX | Novavax, Inc. | 1.73B | 1.45% | 2,800,167 | 413.80M |
| 292 | MAZE | Maze Therapeutics, Inc. | 1.72B | 0.63% | 417,916 | 20.00M |
| 293 | NBTX | Nanobiotix S.A. | 1.72B | -0.53% | 85,569 | 13.15M |
| 294 | CERT | Certara, Inc. | 1.71B | -2.44% | 2,749,164 | 421.75M |
| 295 | PSNL | Personalis, Inc. | 1.70B | -0.47% | 749,241 | 69.67M |
| 296 | STOK | Stoke Therapeutics, Inc. | 1.70B | -0.23% | 1,879,619 | 28.21M |
| 297 | CMPS | COMPASS Pathways plc | 1.69B | -0.73% | 1,382,317 | - |
| 298 | OMCL | Omnicell, Inc. | 1.68B | 2.59% | 841,786 | 1.24B |
| 299 | NUVB | Nuvation Bio Inc. | 1.67B | 3.92% | 6,497,059 | 169.90M |
| 300 | ALHC | Alignment Healthcare, Inc. | 1.67B | -1.47% | 13,586,809 | 4.94B |
| 301 | HCSG | Healthcare Services Group, Inc. | 1.66B | 2.58% | 712,870 | 1.88B |
| 302 | RARE | Ultragenyx Pharmaceutical Inc. | 1.65B | -2.44% | 2,803,763 | 717.00M |
| 303 | REPL | Replimune Group, Inc. | 1.65B | 8.28% | 5,146,006 | - |
| 304 | URGN | UroGen Pharma Ltd. | 1.64B | -0.80% | 1,439,359 | 188.73M |
| 305 | SNDA | Sonida Senior Living, Inc. | 1.62B | 1.93% | 392,624 | 481.07M |
| 306 | IMCR | Immunocore Holdings plc | 1.61B | -4.11% | 1,287,153 | 430.78M |
| 307 | OCUL | Ocular Therapeutix, Inc. | 1.61B | 0.27% | 2,210,806 | 52.06M |
| 308 | LYCA | Lycia Therapeutics, Inc. | 1.60B | 10.70% | 173,149 | 4.44M |
| 309 | TDOC | Teladoc Health, Inc. | 1.59B | 26.89% | 20,129,157 | 2.47B |
| 310 | PAHC | Phibro Animal Health Corporation | 1.58B | 2.59% | 100,825 | 1.52B |
| 311 | ANIP | ANI Pharmaceuticals, Inc. | 1.57B | 2.02% | 262,411 | 978.38M |
| 312 | GPCR | Structure Therapeutics Inc. | 1.56B | 2.14% | 929,516 | - |
| 313 | INVA | Innoviva, Inc. | 1.54B | 0.90% | 626,929 | 440.00M |
| 314 | ETON | Eton Pharmaceuticals, Inc. | 1.53B | 3.61% | 369,438 | 105.60M |
| 315 | NVCR | NovoCure Limited | 1.53B | -7.48% | 5,956,046 | 725.39M |
| 316 | PNTG | The Pennant Group, Inc. | 1.48B | 0.76% | 369,225 | 1.10B |
| 317 | TYRA | Tyra Biosciences, Inc. | 1.48B | -1.24% | 734,903 | - |
| 318 | GHRS | GH Research PLC | 1.48B | 3.81% | 345,219 | - |
| 319 | ANAB | AnaptysBio, Inc. | 1.45B | -3.68% | 414,382 | 106.09M |
| 320 | PCRX | Pacira BioSciences, Inc. | 1.45B | - | 618,951 | 746.16M |
| 321 | AGL | agilon health, inc. | 1.44B | -5.56% | 138,587 | 5.92B |
| 322 | NUTX | Nutex Health Inc. | 1.44B | -1.19% | 79,564 | 846.72M |
| 323 | FRNM | Freenome, Inc. | 1.38B | -4.32% | 360,301 | 35.41M |
| 324 | TNDM | Tandem Diabetes Care, Inc. | 1.38B | 0.56% | 3,357,365 | 1.04B |
| 325 | KRSA | Korsana Biosciences, Inc. | 1.38B | 0.37% | 138,992 | - |
| 326 | TSHA | Taysha Gene Therapies, Inc. | 1.38B | -0.24% | 2,057,816 | 5.49M |
| 327 | OMER | Omeros Corporation | 1.37B | 5.98% | 3,627,920 | 38.42M |
| 328 | CNMD | CONMED Corporation | 1.36B | -0.09% | 482,189 | 1.37B |
| 329 | DMRA | Damora Therapeutics, Inc. | 1.36B | 1.85% | 460,313 | - |
| 330 | KARD | Kardigan, Inc. | 1.34B | 4.22% | 446,391 | - |
| 331 | NKTR | Nektar Therapeutics | 1.34B | 1.63% | 490,300 | 54.59M |
| 332 | ENOV | Enovis Corporation | 1.32B | 4.11% | 1,296,405 | 2.30B |
| 333 | LBRX | LB Pharmaceuticals Inc | 1.30B | 0.80% | 400,679 | - |
| 334 | USPH | U.S. Physical Therapy, Inc. | 1.29B | 1.47% | 105,181 | 804.27M |
| 335 | AAPG | Ascentage Pharma Group International | 1.27B | -0.73% | 11,292 | 94.61M |
| 336 | STAA | STAAR Surgical Company | 1.27B | 2.56% | 454,625 | 339.59M |
| 337 | SNDX | Syndax Pharmaceuticals, Inc. | 1.26B | -1.19% | 4,882,083 | 252.25M |
| 338 | INNV | InnovAge Holding Corp. | 1.26B | 1.54% | 585,551 | 989.71M |
| 339 | SVRA | Savara Inc. | 1.26B | -1.39% | 1,741,308 | - |
| 340 | BVS | Bioventus Inc. | 1.25B | 1.50% | 444,916 | 581.85M |
| 341 | CRON | Cronos Group Inc. | 1.25B | 0.30% | 666,416 | 179.09M |
| 342 | OPK | OPKO Health, Inc. | 1.24B | 2.47% | 1,976,747 | 587.90M |
| 343 | VOR | Vor Biopharma Inc. | 1.24B | 1.26% | 968,249 | - |
| 344 | DRTS | Alpha Tau Medical Ltd. | 1.22B | -0.90% | 293,562 | - |
| 345 | GDRX | GoodRx Holdings, Inc. | 1.21B | 2.02% | 1,437,111 | 785.23M |
| 346 | OMDA | Omada Health, Inc. | 1.20B | 2.45% | 620,081 | 309.76M |
| 347 | SLN | Silence Therapeutics plc | 1.19B | 0.46% | 1,814,667 | 615.00K |
| 348 | CSTL | Castle Biosciences, Inc. | 1.18B | 4.99% | 723,818 | 357.28M |
| 349 | VSTM | Verastem, Inc. | 1.17B | -1.83% | 1,939,759 | 87.53M |
| 350 | PRCT | PROCEPT BioRobotics Corporation | 1.16B | 0.50% | 704,539 | 337.34M |
| 351 | RAPP | Rapport Therapeutics, Inc. | 1.16B | 7.60% | 3,096,811 | 20.00M |
| 352 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.15B | 2.28% | 371,414 | 730.02M |
| 353 | AORT | Artivion, Inc. | 1.14B | 2.27% | 418,196 | 471.47M |
| 354 | AVLN | Avalyn Pharma Inc. | 1.14B | -0.12% | 593,265 | - |
| 355 | AHG | Akso Health Group | 1.14B | 2.31% | 33,069 | 13.83M |
| 356 | SPTX | Seaport Therapeutics, Inc. | 1.13B | 3.53% | 272,148 | - |
| 357 | LMRI | Lumexa Imaging Holdings, Inc. | 1.13B | 0.95% | 200,190 | 1.04B |
| 358 | MNKD | MannKind Corporation | 1.13B | 2.04% | 2,276,256 | 393.63M |
| 359 | HROW | Harrow, Inc. | 1.12B | 2.04% | 321,075 | 275.59M |
| 360 | CTY | City Therapeutics, Inc. | 1.10B | 2.26% | 130,918 | 14.34M |
| 361 | IRMD | IRADIMED CORPORATION | 1.10B | 2.16% | 92,624 | 86.34M |
| 362 | JANX | Janux Therapeutics, Inc. | 1.09B | -1.22% | 905,869 | 24.00M |
| 363 | SGP | SpyGlass Pharma, Inc. | 1.09B | -1.07% | 125,364 | - |
| 364 | INBX | Inhibrx Biosciences, Inc. | 1.08B | 0.49% | 358,741 | 1.30M |
| 365 | MLTX | MoonLake Immunotherapeutics | 1.07B | 2.11% | 4,097,291 | - |
| 366 | CBLL | CeriBell, Inc. | 1.07B | 2.20% | 405,307 | 101.96M |
| 367 | HSTM | HealthStream, Inc. | 1.03B | 0.21% | 129,784 | 321.12M |
| 368 | LTGO | Latigo Biotherapeutics, Inc. | 1.03B | -1.83% | 141,660 | - |
| 369 | SIBN | SI-BONE, Inc. | 1.00B | 2.66% | 950,305 | 213.60M |
| 370 | IMTX | Immatics N.V. | 999.20M | -0.54% | 1,178,906 | 47.65M |
| 371 | IART | Integra LifeSciences Holdings Corporation | 998.19M | 4.82% | 1,188,114 | 1.66B |
| 372 | CGEM | Cullinan Therapeutics, Inc. | 994.28M | -0.71% | 460,065 | - |
| 373 | RIGL | Rigel Pharmaceuticals, Inc. | 961.08M | 1.40% | 159,560 | 276.79M |
| 374 | BBNX | Beta Bionics, Inc. | 955.77M | -1.51% | 1,288,478 | 127.27M |
| 375 | ODTX | Odyssey Therapeutics, Inc. | 950.22M | 1.48% | 212,834 | 99.00K |
| 376 | QDEL | QuidelOrtho Corporation | 943.60M | -1.78% | 1,509,011 | 2.67B |
| 377 | KURA | Kura Oncology, Inc. | 939.42M | -1.49% | 1,590,500 | 77.23M |
| 378 | AKTS | Aktis Oncology, Inc. | 937.19M | 0.18% | 245,682 | 10.06M |
| 379 | PRME | Prime Medicine, Inc. | 932.22M | -2.24% | 10,354,578 | 4.07M |
| 380 | MGTX | MeiraGTx Holdings plc | 932.10M | -0.46% | 499,165 | 397.50M |
| 381 | ORIC | ORIC Pharmaceuticals, Inc. | 931.84M | -3.33% | 1,046,758 | - |
| 382 | GLUE | Monte Rosa Therapeutics, Inc. | 927.36M | 0.18% | 1,307,288 | 28.73M |
| 383 | ANRO | Alto Neuroscience, Inc. | 921.01M | 0.60% | 388,833 | - |
| 384 | JBIO | Jade Biosciences, Inc. | 905.63M | -2.40% | 896,090 | - |
| 385 | PACB | Pacific Biosciences of California, Inc. | 901.41M | 2.47% | 11,974,068 | 159.27M |
| 386 | OBX | Obsidian Therapeutics, Inc. | 896.94M | -0.48% | 248,152 | - |
| 387 | ALMS | Alumis Inc. | 891.81M | -3.37% | 2,743,468 | 7.40M |
| 388 | GMRS | GMR Solutions Inc. | 887.58M | 4.58% | 958,113 | 5.88B |
| 389 | IVA | Inventiva S.A. | 882.39M | 0.54% | 1,435,325 | 2.81M |
| 390 | CRVS | Corvus Pharmaceuticals, Inc. | 860.56M | -2.76% | 852,694 | - |
| 391 | DNA | Ginkgo Bioworks Holdings, Inc. | 857.92M | -4.35% | 2,897,833 | 132.42M |
| 392 | PHAR | Pharming Group N.V. | 854.21M | -1.06% | 12,424 | 386.75M |
| 393 | ABUS | Arbutus Biopharma Corporation | 846.79M | -0.93% | 1,209,733 | 181.72M |
| 394 | KIDS | OrthoPediatrics Corp. | 823.00M | 2.34% | 834,923 | 264.14M |
| 395 | CTKB | Cytek Biosciences, Inc. | 818.89M | 2.61% | 1,914,842 | 206.71M |
| 396 | SANA | Sana Biotechnology, Inc. | 814.26M | 3.42% | 3,308,631 | - |
| 397 | AHCO | AdaptHealth Corp. | 791.12M | -1.66% | 2,084,579 | 3.36B |
| 398 | AVBP | ArriVent BioPharma, Inc. | 786.46M | 1.40% | 658,314 | - |
| 399 | HELP | Helus Pharma Inc. | 782.47M | -1.83% | 790,340 | - |
| 400 | COLL | Collegium Pharmaceutical, Inc. | 782.31M | 3.44% | 656,455 | 808.21M |
| 401 | PHR | Phreesia, Inc. | 777.75M | 1.29% | 612,696 | 507.79M |
| 402 | VREX | Varex Imaging Corporation | 777.21M | -0.05% | 1,043,532 | 865.00M |
| 403 | INMD | InMode Ltd. | 776.57M | 1.05% | 370,605 | 374.63M |
| 404 | ARDX | Ardelyx, Inc. | 772.48M | - | 2,550,076 | 450.89M |
| 405 | OABI | OmniAb, Inc. | 760.39M | -0.95% | 1,683,584 | 38.46M |
| 406 | ANNX | Annexon, Inc. | 760.21M | -0.74% | 3,284,984 | - |
| 407 | ACHV | Achieve Life Sciences, Inc. | 739.87M | 4.96% | 1,375,111 | - |
| 408 | SGMT | Sagimet Biosciences Inc. | 739.58M | -2.89% | 746,454 | - |
| 409 | APMD | Apnimed, Inc. | 721.88M | -9.45% | 1,011,730 | 115.12M |
| 410 | WVE | Wave Life Sciences, Inc. | 715.94M | -0.27% | 3,593,651 | 70.92M |
| 411 | FDMT | 4D Molecular Therapeutics, Inc. | 706.02M | -1.16% | 848,927 | 92.01M |
| 412 | ATTO | Attovia Therapeutics, Inc. | 697.09M | -3.35% | 413,809 | 1.80M |
| 413 | DSGN | Design Therapeutics, Inc. | 692.15M | -0.18% | 276,605 | - |
| 414 | SLDB | Solid Biosciences Inc. | 685.17M | -1.39% | 964,670 | - |
| 415 | GYRE | Gyre Therapeutics, Inc. | 679.68M | -9.59% | 185,320 | 109.82M |
| 416 | SOPH | SOPHiA GENETICS SA | 678.47M | 1.27% | 208,056 | 86.17M |
| 417 | STLN | Starling Oncology, Inc. | 677.74M | 0.15% | 1,107,732 | 587.24M |
| 418 | IAM | Iambic Therapeutics, Inc. | 676.88M | -3.38% | 270,816 | 18.25M |
| 419 | SLBT | SL Science Holding Limited | 667.21M | -3.31% | 24,561 | 3.27M |
| 420 | ANL | Adlai Nortye Group Ltd. | 662.01M | 0.78% | 44,560 | 18.06M |
| 421 | CADL | Candel Therapeutics, Inc. | 661.89M | -0.23% | 740,959 | - |
| 422 | IMMX | Immix Biopharma, Inc. | 661.57M | -1.85% | 1,073,788 | - |
| 423 | LXRX | Lexicon Pharmaceuticals, Inc. | 658.53M | -0.34% | 1,772,641 | 41.47M |
| 424 | AURA | Aura Biosciences, Inc. | 652.82M | -1.64% | 769,976 | - |
| 425 | BCAX | Bicara Therapeutics Inc. | 643.86M | -0.31% | 3,197,674 | - |
| 426 | OLMA | Olema Pharmaceuticals, Inc. | 641.36M | -2.14% | 1,153,498 | - |
| 427 | MYGN | Myriad Genetics, Inc. | 637.98M | 0.60% | 1,470,798 | 806.60M |
| 428 | AVR | Anteris Technologies Global Corp. | 625.91M | 5.25% | 2,822,308 | 2.24M |
| 429 | ACRS | Aclaris Therapeutics, Inc. | 618.39M | 0.76% | 1,458,758 | 8.22M |
| 430 | ZVRA | Zevra Therapeutics, Inc. | 615.22M | 0.48% | 507,872 | 136.07M |
| 431 | GERN | Geron Corporation | 607.91M | -2.30% | 32,350,410 | 204.56M |
| 432 | NVCT | Nuvectis Pharma, Inc. | 605.04M | 1.14% | 117,687 | - |
| 433 | CBIO | Crescent Biopharma, Inc. | 602.21M | 4.22% | 378,022 | 11.88M |
| 434 | DBVT | DBV Technologies S.A. | 601.28M | -3.38% | 1,033,826 | 3.76M |
| 435 | IRWD | Ironwood Pharmaceuticals, Inc. | 598.17M | 0.28% | 1,367,777 | 389.32M |
| 436 | FLGT | Fulgent Genetics, Inc. | 596.53M | 0.74% | 210,288 | 323.93M |
| 437 | CRMD | CorMedix Inc. | 595.49M | -6.83% | 1,887,156 | 462.25M |
| 438 | CLYM | Climb Bio, Inc. | 593.32M | 2.08% | 688,983 | - |
| 439 | EVO | Evotec SE | 581.45M | -1.56% | 64,145 | 819.47M |
| 440 | MDXG | MiMedx Group, Inc. | 579.32M | 0.51% | 4,044,146 | 303.73M |
| 441 | NGNE | Neurogene Inc. | 576.73M | -5.26% | 309,996 | 925.00K |
| 442 | STTK | Shattuck Labs, Inc. | 574.08M | -1.55% | 676,327 | 1.00M |
| 443 | DRUG | Bright Minds Biosciences Inc. | 559.97M | 2.48% | 67,541 | - |
| 444 | TCMD | Tactile Systems Technology, Inc. | 550.68M | 1.67% | 157,907 | 350.31M |
| 445 | PBYI | Puma Biotechnology, Inc. | 544.08M | -0.75% | 224,287 | 231.24M |
| 446 | ENTX | Entera Bio Ltd. | 542.64M | 0.65% | 140,952 | 42.00K |
| 447 | ETRA | Electra Therapeutics, Inc. | 542.31M | -3.79% | 166,476 | - |
| 448 | VALN | Valneva SE | 541.61M | -0.52% | 11,516 | 163.30M |
| 449 | MASS | 908 Devices Inc. | 531.14M | -0.16% | 223,027 | 60.84M |
| 450 | SGHT | Sight Sciences, Inc. | 527.19M | 3.57% | 346,458 | 83.38M |
| 451 | ANGO | AngioDynamics, Inc. | 519.37M | 1.81% | 476,190 | 325.38M |
| 452 | RCEL | AVITA Medical, Inc. | 516.79M | 1.27% | 312,933 | 75.63M |
| 453 | ARVN | Arvinas, Inc. | 516.55M | 3.95% | 863,796 | 316.70M |
| 454 | SENS | Senseonics Holdings, Inc. | 515.52M | 4.39% | 522,676 | 48.55M |
| 455 | SRZN | Surrozen, Inc. | 515.41M | -2.93% | 254,727 | 11.51M |
| 456 | DMAC | DiaMedica Therapeutics Inc. | 513.37M | -3.05% | 196,511 | - |
| 457 | INDP | Indaptus Therapeutics, Inc. | 512.96M | 0.30% | 84,369 | - |
| 458 | OCS | Oculis Holding AG | 508.67M | 3.26% | 263,729 | 1.45M |
| 459 | DCTH | Delcath Systems, Inc. | 507.99M | -1.48% | 239,254 | 95.42M |
| 460 | AQST | Aquestive Therapeutics, Inc. | 507.07M | -4.49% | 2,018,392 | 54.09M |
| 461 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 462 | OVID | Ovid Therapeutics Inc. | 499.96M | 4.49% | 2,043,940 | 1.58M |
| 463 | TKNO | Alpha Teknova, Inc. | 499.17M | 2.93% | 679,702 | 43.70M |
| 464 | CTMX | CytomX Therapeutics, Inc. | 498.99M | -2.97% | 4,629,273 | 18.30M |
| 465 | NRC | NRC Health | 498.49M | 0.09% | 124,936 | 143.79M |
| 466 | EOLS | Evolus, Inc. | 496.70M | -1.57% | 789,232 | 316.49M |
| 467 | PHAT | Phathom Pharmaceuticals, Inc. | 494.06M | -0.96% | 3,843,453 | 274.88M |
| 468 | CERS | Cerus Corporation | 491.72M | 0.83% | 1,353,264 | 221.55M |
| 469 | RGNX | REGENXBIO Inc. | 489.16M | 2.35% | 1,035,604 | 174.48M |
| 470 | FTH | Faeth Therapeutics, Inc. | 484.51M | -2.34% | 280,960 | - |
| 471 | BLSM | BlossomHill Therapeutics, Inc. | 483.45M | -7.59% | 98,956 | - |
| 472 | MNPR | Monopar Therapeutics Inc. | 482.67M | -2.02% | 163,110 | - |
| 473 | EVH | Evolent Health, Inc. | 480.50M | -1.85% | 1,302,463 | 2.10B |
| 474 | EPRX | Eupraxia Pharmaceuticals Inc. | 477.93M | -1.76% | 1,015,479 | - |
| 475 | SSII | SS Innovations International, Inc. | 476.92M | -2.46% | 95,162 | 52.40M |
| 476 | BWAY | BrainsWay Ltd. | 473.09M | 4.93% | 121,733 | 60.70M |
| 477 | PRTA | Prothena Corporation plc | 455.87M | -2.42% | 370,070 | 54.53M |
| 478 | KMDA | Kamada Ltd. | 454.53M | -0.62% | 65,822 | 191.85M |
| 479 | EDIT | Editas Medicine, Inc. | 449.99M | -0.68% | 3,226,683 | 47.01M |
| 480 | NPCE | NeuroPace, Inc. | 446.56M | 0.62% | 104,558 | 106.99M |
| 481 | PROK | ProKidney Corp. | 444.41M | -3.29% | 821,229 | 818.00K |
| 482 | RZLT | Rezolute, Inc. | 432.17M | -2.37% | 756,260 | - |
| 483 | ALLO | Allogene Therapeutics, Inc. | 431.86M | -3.85% | 7,714,559 | 4.64M |
| 484 | CARL | Carlsmed, Inc. | 430.56M | 3.00% | 58,621 | 63.30M |
| 485 | MPLT | MapLight Therapeutics, Inc. | 429.04M | -3.26% | 156,727 | - |
| 486 | SI | Shoulder Innovations, Inc. | 425.54M | 4.93% | 144,827 | 60.06M |
| 487 | ASMB | Assembly Biosciences, Inc. | 424.72M | 1.41% | 198,755 | 74.85M |
| 488 | PRLD | Prelude Therapeutics Incorporated | 422.28M | -0.97% | 201,320 | 22.42M |
| 489 | AUTL | Autolus Therapeutics plc | 420.54M | -3.07% | 2,347,068 | 117.39M |
| 490 | SRTA | Strata Critical Medical, Inc. | 420.22M | -0.21% | 1,246,545 | 255.98M |
| 491 | OFIX | Orthofix Medical Inc. | 417.10M | 1.99% | 399,257 | 833.19M |
| 492 | ALT | Altimmune, Inc. | 416.27M | 1.90% | 2,684,155 | 31.00K |
| 493 | YDES | YD Bio Limited | 415.78M | -6.53% | 96,184 | 1.24M |
| 494 | CTEV | Claritev Corporation | 406.74M | 4.35% | 284,912 | 994.67M |
| 495 | CCCC | C4 Therapeutics, Inc. | 405.98M | -2.80% | 2,715,032 | 35.04M |
| 496 | TECX | Tectonic Therapeutic, Inc. | 400.76M | -0.29% | 139,593 | - |
| 497 | NAUT | Nautilus Biotechnology, Inc. | 399.95M | -2.18% | 7,508,804 | 424.00K |
| 498 | AVTX | Avalo Therapeutics, Inc. | 399.01M | 4.49% | 2,274,215 | 59.00K |
| 499 | AGMB | AgomAb Therapeutics NV | 391.52M | -0.13% | 575,394 | - |
| 500 | TLRY | Tilray Brands, Inc. | 387.19M | -1.86% | 4,210,042 | 963.10M |